What would you offer as adjuvant therapy for a resected stage IIIB adeno NSCLC in a patient who refuses chemotherapy?
Can adjuvant durvalumab or other I/O or osimertinib (if EGFR+) be considered?
Answer from: Medical Oncologist at Community Practice
Patients with stage III NSCLC are at very high risk for recurrence, and in this situation, I would make sure that your discussions with the patient highlight this clearly. My usual thought is that if a patient can tolerate and recover from lobectomy/resection, then that is a reasonable indication th...
Comments
Medical Oncologist at Cancer Specialists of North Florida Thank you so much for the input.
Answer from: Medical Oncologist at Community Practice
I would definitely have an honest conversation with the patient about high risk of relapse. Sometimes it's just addressing the barriers and fears associated with chemotherapy. Like Dr. @Dwight Owen mentioned, using carboplatin does significantly decrease the platinum related AE's. Sometimes I tend t...
Comments
Medical Oncologist at Intermountain Healthcare Curious about your observation that paclitaxel/gem...
Thank you so much for the input.